These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3217823)

  • 1. Field trial of oral cholera vaccines in Bangladesh.
    Clemens JD; Harris JR; Sack DA; Chakraborty J; Ahmed F; Stanton BF; Huda N; Khan MR; Khan MU; Kay BA
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):417-22. PubMed ID: 3217823
    [No Abstract]   [Full Text] [Related]  

  • 2. [The oral cholera vaccine project; the first 3 years of field work in Bangladesh].
    van Loon FP
    Ned Tijdschr Geneeskd; 1991 Jan; 135(3):87-9. PubMed ID: 1996165
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral vaccines for cholera control.
    Chaturvedi S; Chaturvedi S
    Natl Med J India; 1997; 10(1):17-8. PubMed ID: 9069701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Questionable merits of the field trial of an oral killed whole cell cholera vaccine in Vietnam during 1998-2003.
    Kabir S
    Vaccine; 2007 Feb; 25(8):1353-4. PubMed ID: 17049687
    [No Abstract]   [Full Text] [Related]  

  • 6. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up.
    Clemens JD; Sack DA; Harris JR; Van Loon F; Chakraborty J; Ahmed F; Rao MR; Khan MR; Yunus M; Huda N
    Lancet; 1990 Feb; 335(8684):270-3. PubMed ID: 1967730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between neighbourhood-level killed oral cholera vaccine coverage and protective efficacy: evidence for herd immunity.
    Emch M; Ali M; Park JK; Yunus M; Sack DA; Clemens JD
    Int J Epidemiol; 2006 Aug; 35(4):1044-50. PubMed ID: 16723370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects for control of cholera with oral vaccines.
    Sack RB
    J Diarrhoeal Dis Res; 1992 Mar; 10(1):1-3. PubMed ID: 1619235
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimating the cost of cholera-vaccine delivery from the societal point of view: A case of introduction of cholera vaccine in Bangladesh.
    Sarker AR; Islam Z; Khan IA; Saha A; Chowdhury F; Khan AI; Cravioto A; Clemens JD; Qadri F; Khan JA
    Vaccine; 2015 Sep; 33(38):4916-21. PubMed ID: 26232545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding.
    Ahmed T; Svennerholm AM; Al Tarique A; Sultana GN; Qadri F
    Vaccine; 2009 Feb; 27(9):1433-9. PubMed ID: 19146904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herd protection and herd amplification in cholera.
    Sack DA
    J Health Popul Nutr; 2006 Mar; 24(1):1-5. PubMed ID: 16796143
    [No Abstract]   [Full Text] [Related]  

  • 12. A controlled field trial on the effectiveness of the intradermal and subcutaneous administration of cholera vaccine in the Philippines.
    Philippines Cholera Committee
    Bull World Health Organ; 1973; 49(4):389-94. PubMed ID: 4603994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholera: developments in prevention and cure.
    van Loon FP
    Trop Geogr Med; 1993; 45(6):269-73. PubMed ID: 8116056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam.
    Trach DD; Cam PD; Ke NT; Rao MR; Dinh D; Hang PV; Hung NV; Canh DG; Thiem VD; Naficy A; Ivanoff B; Svennerholm AM; Holmgren J; Clemens JD
    Bull World Health Organ; 2002; 80(1):2-8. PubMed ID: 11884967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation in tablets of a cholera whole cells inactivated vaccine candidate.
    Talavera A; Año G; Pino Y; Castaño J; Uribarri E; Riverón L; Gil S; Fernández S; Cedré B; Valmaseda T; Pérez JL; Infante JF; García L; Sierra G
    Vaccine; 2006 Apr; 24(16):3381-7. PubMed ID: 16460846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam.
    Vu DT; Hossain MM; Nguyen DS; Nguyen TH; Rao MR; Do GC; Naficy A; Nguyen TK; Acosta CJ; Deen JL; Clemens JD; Dang DT
    J Health Popul Nutr; 2003 Dec; 21(4):304-8. PubMed ID: 15043004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis.
    Ali M; Emch M; von Seidlein L; Yunus M; Sack DA; Rao M; Holmgren J; Clemens JD
    Lancet; 2005 Jul 2-8; 366(9479):44-9. PubMed ID: 15993232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up.
    van Loon FP; Clemens JD; Chakraborty J; Rao MR; Kay BA; Sack DA; Yunus M; Ali M; Svennerholm AM; Holmgren J
    Vaccine; 1996 Feb; 14(2):162-6. PubMed ID: 8852414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy calculation in randomized trials: global or local measures?
    Emch M; Ali M; Acosta C; Yunus M; Sack DA; Clemens JD
    Health Place; 2007 Mar; 13(1):238-48. PubMed ID: 16529974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial.
    Qadri F; Ali M; Chowdhury F; Khan AI; Saha A; Khan IA; Begum YA; Bhuiyan TR; Chowdhury MI; Uddin MJ; Khan JAM; Chowdhury AI; Rahman A; Siddique SA; Asaduzzaman M; Akter A; Khan A; Ae You Y; Siddik AU; Saha NC; Kabir A; Riaz BK; Biswas SK; Begum F; Unicomb L; Luby SP; Cravioto A; Clemens JD
    Lancet; 2015 Oct; 386(10001):1362-1371. PubMed ID: 26164097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.